Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Roy S. Herbst Adrian Harris Luca Gianni |
| Publication date | June 1, 2003 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |